Randomized trials of adjuvant tamoxifen versus tamoxifen and octreotide LAR in early-stage breast cancer: NCIC CTG MA.14 and NSABP B-29. This is an ASCO Meeting Abstract from the 2012 ASCO Annual ...
Primary results from EMILIA, a phase III study of trastuzumab emtansine (T-DM1) versus capecitabine (X) and lapatinib (L) in HER2-positive locally advanced or metastatic breast cancer (MBC) previously ...
Dr. Debu Tripathy explains the updated results of the BOLERO-2 study, which looked at Afinitor (everolimus) and an aromatase inhibitor in metastatic breast cancer. How useful will this new drug be in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results